Trial
NCT03878927
CPX-351+GO in Subjects 55 Years Old, or Older, With AML
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Weill Medical College of Cornell University
Collaborators
Jazz Pharmaceuticals; Pfizer
Condition
Acute Myeloid Leukemia
Intervention
CPX-351
Why stopped
Dose limiting toxicities.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-10